KRAS and MET in non-small-cell lung cancer: two of the new kids on the ‘drivers’ block

Non-small-cell lung cancer (NSCLC) is a heterogeneous disease, and therapeutic management has advanced to identify various critical oncogenic mutations that promote lung cancer tumorigenesis. Subsequent studies have developed targeted therapies against these oncogenes in the hope of personalized tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Robledo, Juan Esteban, Rosell, Rafael, Ruíz-Patiño, Alejandro, Sotelo, Carolina, Arrieta, Oscar, Zatarain-Barrón, Lucia, Ordoñez, Camila, Jaller, Elvira, Rojas, Leonardo, Russo, Alessandro, de Miguel-Pérez, Diego, Rolfo, Christian, Cardona, Andrés F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808025/
https://www.ncbi.nlm.nih.gov/pubmed/35098800
http://dx.doi.org/10.1177/17534666211066064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808025/
https://www.ncbi.nlm.nih.gov/pubmed/35098800
http://dx.doi.org/10.1177/17534666211066064

Ejemplares similares